The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

The global age-standardized incidence and prevalence rates of RA increased from 1990 to 2021 while mortality rates declined.

Metformin was associated with significantly reduced knee pain among patients with overweight/obesity and knee osteoarthritis.

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.

Neuraxial anesthesia is associated with significantly reduced odds of several major postoperative complications in patients undergoing hip fracture procedures, according to resear ...

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.

More than one-third of patients with SSc screened positive for self-reported depression, with GI involvement identified as the most significant predictor.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Supervised combined exercises and neuromuscular training may be the most effective NPIs for improving disease activity, function, and spinal mobility in axSpA.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.